Crispr Therapeutics shares owned by Vanguard Investments Australia
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vanguard Investments Australia
from 13F filings
Historical chart of Vanguard Investments Australia investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Vanguard Investments Australia consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Vanguard Investments Australia
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.0M | 22k | 47.57 |
More positions owned by Vanguard Investments Australia
View all positions for Vanguard Investments Australia